Chembio Diagnostics, Inc. announced the appointment of Christine M. Rousseau, Ph.D. as Vice President, Corporate Development, effective immediately. In this newly created position, Dr. Rousseau will focus on the Company’s POC infectious disease diagnostics strategy and execution, including HIV Self-Testing and Fever & Tropical Diseases, as well as technology collaborations that leverage the Company’s patented DPP® technology platform and scientific expertise. Prior to joining Chembio, Dr. Rousseau spent nine years at the Bill & Melinda Gates Foundation, most recently serving as Senior Program Officer, Global Health, Integrated Technology Solutions.